Correlation Between Phibro Animal and Cyclo Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Phibro Animal and Cyclo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Phibro Animal and Cyclo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Phibro Animal Health and Cyclo Therapeutics, you can compare the effects of market volatilities on Phibro Animal and Cyclo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Phibro Animal with a short position of Cyclo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Phibro Animal and Cyclo Therapeutics.

Diversification Opportunities for Phibro Animal and Cyclo Therapeutics

0.47
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Phibro and Cyclo is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Phibro Animal Health and Cyclo Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cyclo Therapeutics and Phibro Animal is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Phibro Animal Health are associated (or correlated) with Cyclo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cyclo Therapeutics has no effect on the direction of Phibro Animal i.e., Phibro Animal and Cyclo Therapeutics go up and down completely randomly.

Pair Corralation between Phibro Animal and Cyclo Therapeutics

Given the investment horizon of 90 days Phibro Animal is expected to generate 3.77 times less return on investment than Cyclo Therapeutics. But when comparing it to its historical volatility, Phibro Animal Health is 3.2 times less risky than Cyclo Therapeutics. It trades about 0.08 of its potential returns per unit of risk. Cyclo Therapeutics is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  60.00  in Cyclo Therapeutics on December 2, 2024 and sell it today you would earn a total of  16.00  from holding Cyclo Therapeutics or generate 26.67% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Phibro Animal Health  vs.  Cyclo Therapeutics

 Performance 
       Timeline  
Phibro Animal Health 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Phibro Animal Health has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical indicators, Phibro Animal is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
Cyclo Therapeutics 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Cyclo Therapeutics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak basic indicators, Cyclo Therapeutics demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Phibro Animal and Cyclo Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Phibro Animal and Cyclo Therapeutics

The main advantage of trading using opposite Phibro Animal and Cyclo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Phibro Animal position performs unexpectedly, Cyclo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyclo Therapeutics will offset losses from the drop in Cyclo Therapeutics' long position.
The idea behind Phibro Animal Health and Cyclo Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals